Endogenous Amplification of Apoptosis via p53 Regulation using a Cascade Nanocatalytic Medicine
Advanced Science · 2026
DOI: 10.1002/advs.202520367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Tan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research…. Hauptthemen laut MEDLINE: Apoptosis, Tumor Suppressor Protein p53, Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Committee of Science and Technology for Program of Shanghai Academic/Technology Research Leader, National Natural Science Foundation of China, Shanghai Academic/Technology Research Leader.
Abstract (Originalsprache)
Nanocatalytic therapy is an emerging strategy that leverages in situ catalytic reactions within the tumor microenvironment to convert endogenous substrates into cytotoxic species, achieving spatially confined cancer cell killing with reduced systemic toxicity. However, the lack of durable, DNA‐focused cytotoxic mechanisms hampers the translational efficacy of nanocatalytic therapy. Herein, we proposed a cascade nanocatalysis‐mediated strategy for endogenous amplification of apoptosis, achieved by an engineered metal organic framework nanomedicine (MOF‐Au‐L‐Arginine, abbreviated as MAL). The MOF serves both as a nanocatalyst and as a carrier for L‐Arginine (L‐Arg), while embedded Au nanoparticles enhance nanocatalyst reactivity. Subsequently, MOF catalyzes the generation of hydroxyl radicals (•OH) and superoxide anions (O 2 •− ), and then the O 2 •− undergo a cascade reaction with NO released from L‐Arg, generating highly cytotoxic peroxynitrite (ONOO–), which has greater cytotoxicity to tumor cells, can induce extensive DNA damage, and simultaneously impair DNA repair and disrupt the cell cycle. Genome‐wide RNA sequencing reveals MAL can activate the p53 pathway, thereby regulating apoptosis related proteins. In addition, MAL reduces mitochondrial membrane potential and promotes mitochondrial‐mediated apoptosis through the BAX/Bcl‐2/caspase‐3 axis, further amplifying endogenous apoptosis in tumor cells. In vivo, MAL effectively inhibits tumor growth with favorable biocompatibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative medicine, Shanghai Key Laboratory of Anesthesiology and Brain Functional Modulation, Clinical Research Center For Anesthesiology and Perioperative Medicine, Translational R…
- Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Nephrology, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.
Förderung
- Shanghai Municipal Committee of Science and Technology for Program of Shanghai Academic/Technology Research Leader
- National Natural Science Foundation of China
- Shanghai Academic/Technology Research Leader
- Shanghai Rising-Star Program
- Hongkou District Health Commission
- Tongji University
- Shanghai Fourth People's Hospital
- School of Medicine, Tongji University
Zitieren
APA
Wu, T., Xu, X., Xu, D., Zhang, H., Wang, N., Yang, Y., Chen, Q., Chen, S., & Li, C. (2026). Endogenous Amplification of Apoptosis via p53 Regulation using a Cascade Nanocatalytic Medicine. Advanced Science. https://doi.org/10.1002/advs.202520367
Vancouver
Wu T, Xu X, Xu D, Zhang H, Wang N, Yang Y, et al. Endogenous Amplification of Apoptosis via p53 Regulation using a Cascade Nanocatalytic Medicine. Advanced Science. 2026. doi:10.1002/advs.202520367
BibTeX
@article{Wu2026,
author = {Wu, Tan and Xu, Xiaoyue and Xu, Dan and Zhang, Hui and Wang, Nan and Yang, Yang and Chen, Qian and Chen, Shunjie and Li, Cheng},
title = {Endogenous Amplification of Apoptosis via p53 Regulation using a Cascade Nanocatalytic Medicine},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202520367}
}
EUVIMED